It is noteworthy Tirzepatide has agonistic properties towards two (2) gut hormone receptors
NOTE: This is for customers who have purchased a non-oral version from us before
"This study suggests oral semaglutide may help reduce heavy and harmful drinking, even in people who are not trying to quit alcohol entirely," Joseph Schacht, an associate professor at the CU Anschutz School of Medicine, explained in a statement
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
A tocopherol and/or actos-controlled clinical trial (NCT05813249) concluded on April 2, 2024, assessing the effects of oral and subcutaneous SEMS on hepatic steatosis and fibrosis improvement in MASLD with T2DM